| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to pharmaceutical industry, namely to a preparation for treating an inflammatory condition related to ischemia. A pharmaceutical preparation for treating the internal inflammatory condition related to ischemia containing: a) normal saline containing at least 10peripheral mononuclear cells (PMC) or their population per one ml, or b) supernatant of normal saline a), wherein normal saline a) is prepared by culturing the PMC or their population in normal saline free from PMC-proliferating or PMC-activating substances; the PMC or their population is cultured in the environment causing the pre- or intra-culture stress. Using the preparation for producing a therapeutic agent for treating the internal inflammatory condition related to ischemia. A method for preparing the pharmaceutical preparation.EFFECT: pharmaceutical preparation possesses higher clinical effectiveness in the internal inflammatory processes related to ischemia.13 cl, 20 dwg, 6 ex |
